CoChat
Sign Up
Cited by 138Epilepsy research and treatmentCOVID-19 and healthcare impactsTelemedicine and Telehealth Implementation

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Keeping people with epilepsy safe during the COVID-19 pandemic

Open access
French, Jacqueline A., Brodie, Martin J., Caraballo, Roberto, Devinsky, Orrin, Ding, Ding, Jehi, Lara, Jette, Nathalie, Kanner, Andres, Modi, Avani C., Newton, Charles R., Patel, Archana A., Pennell, Page B., Perucca, Emilio, Sander, Josemir W., Scheffer, Ingrid E., Singh, Gagandeep, Williams, Emma, Wilmshurst, Jo, Cross, J. Helen·2020·Neurology
DOI 10.1212/wnl.0000000000009632PMC PMC7455365
Open this paper in CoChat — free account

Abstract

OBJECTIVES: To provide information on the effect of the coronavirus disease of 2019 (COVID-19) pandemic on people with epilepsy and provide consensus recommendations on how to provide the best possible care for people with epilepsy while avoiding visits to urgent care facilities and hospitalizations during the novel coronavirus pandemic. METHODS: The authors developed consensus statements in 2 sections. The first was "How should we/clinicians modify our clinical care pathway for people with epilepsy during the COVID-19 pandemic?" The second was "What general advice should we give to people with epilepsy during this crisis? The authors individually scored statements on a scale of -10 (strongly disagree) to +10 (strongly agree). Five of 11 recommendations for physicians and 3/5 recommendations for individuals/families were rated by all the authors as 7 or above (strongly agree) on the first round of rating. Subsequently, a teleconference was held where statements for which there was a lack of strong consensus were revised. RESULTS: After revision, all consensus recommendations received a score of 7 or above. The recommendations focus on administration of as much care as possible at home to keep people with epilepsy out of health care facilities, where they are likely to encounter COVID-19 (including strategies for rescue therapy), as well as minimization of risk of seizure exacerbation through adherence, and through ensuring a regular supply of medication. We also provide helpful links to additional helpful information for people with epilepsy and health providers. CONCLUSION: These recommendations may help health care professionals provide optimal care to people with epilepsy during the coronavirus pandemic.

Overview

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000009632

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 17 references

Research works printed but not linked: 2

  1. 10.1016/j.ijantimicag.2020.105923.105923 · DOI
  2. Plaquenil-hydroxychloroquine Sulfate. Summary of Product Characteristics. Available at: medicines.org.uk/emc/product/1764/smpc. Accessed March 26, 2020.

Cited by

Sorted by citations

Items 101–138 of 138

Related

See all

Metadata

Authors
French, J. A., Brodie, M. J., Caraballo, R., Devinsky, O., Ding, D., Jehi, L., Jette, N., Kanner, A., Modi, A. C., Newton, C. R., Patel, A. A., Pennell, P. B., Perucca, E., Sander, J. W., Scheffer, I. E., Singh, G., Williams, E., Wilmshurst, J., & Cross, J. H.
Affiliations
  • Cleveland Clinic (US)
  • From the Department Neurology (J.A.F.), NYU Grossman School of Medicine New York University, NY; Epilepsy Unit (M.J.B.), International Bureau for Epilepsy, Scottish Epilepsy Initiative, Glasgow, Scotland; Neurology (R.C.), Hospital J P Garrahan, Buenos Aires, AR; Department Neurology (O.D.), NYU Grossman School of Medicine, NY; Institute of Neurology (D.D.), Huashan Hospital, Fudan University, Shanghai, China; Cleveland Clinic Epilepsy Center (L.J.), Cleveland, OH; Department of Neurology (N.J.),...
ORCID
Venue
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2020-06-09
Volume
94
Issue
23
Pages
1032-1037
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
DOI
10.1212/wnl.0000000000009632
PMC
PMC7455365
OpenAlex
W3018838468
Cited by
138
References
17
Citations by year
2026: 1 · 2025: 1 · 2024: 6 · 2023: 12 · 2022: 14 · 2021: 45 · 2020: 58
FWCI
23.53
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Conicet (submittedVersion, cc-by-nc-sa)
Funders
  • March of Dimes Foundation
  • Epilepsy Foundation
  • Pfizer
  • GlaxoSmithKline
  • Sanofi
  • Biogen
  • Patient-Centered Outcomes Research Institute (U24NS107201, IU54NS100064)
  • Sunovion
  • Vitaflo
  • Waterloo Foundation
  • Zogenix
  • Ultragenyx Pharmaceutical
  • GW Pharmaceuticals
  • Zynerba Pharmaceuticals
  • Amicus Therapeutics
  • SK Life Science
  • Springworks Therapeutics
  • National Institute for Health and Care Research (NF-SI-0515-10073)
  • Epilepsy Research UK
  • University College London
  • Great Ormond Street Hospital Charity
  • Eisai
  • Otsuka Pharmaceutical
  • H. Lundbeck A/S
  • Sun Pharma
  • Epilepsiatutkimussäätiö
  • Idorsia Pharmaceuticals
  • Epilepsy Society
  • Intas Pharmaceuticals
  • Arvelle Therapeutics
  • National Institutes of Health (IU54NS100064)
  • Medical Research Council
  • Engineering and Physical Sciences Research Council
  • National Health and Medical Research Council
  • Health Research Council of New Zealand
  • National Institute of Nursing Research
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Neurological Disorders and Stroke (NIH U24NS107201, IU54NS100064, U24NS107201, NIH IU54NS100064)
  • UCB Pharma
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
Keywords
epilepsy, COVID-19 pandemic, care pathways, telemedicine, home care, salvage therapy, drug supply, seizure exacerbation, consensus recommendations
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Epilepsy, Humans, Pneumonia, Viral, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review